首页> 外文期刊>International Journal of Research in Medical Sciences >Sweet syndrome: a sweet disease with a bitter diagnosis
【24h】

Sweet syndrome: a sweet disease with a bitter diagnosis

机译:甜综合征:诊断为苦的甜病

获取原文
           

摘要

Sweet syndrome is an acute febrile neutrophilic dermatosis first described by Robert Douglas Sweet in 1964. Sweet syndrome presents in three clinical settings: classical (or idiopathic), malignancy-associated, and drug-induced. It has been associated with hematopoietic malignancies and myelodysplastic disorders. A-28-years married woman presented to us with chief complaints of Fever and Multiple swellings over the body since 2 months. At presentation she has Pallor; venous hum present. Multiple, tender, erythematous subcutaneous swellings, firm in consistency noted in both forearms. Skin over the swellings is pinchable; superficial skin is normal. Sweet syndrome can occasionally cause an intense systemic response involving the lungs, liver and musculoskeletal system. The skin lesions in Sweet syndrome typically start as erythematous papules, plaques, and nodules. The lesions can take on pseudovesicular or pseudopustular appearance, and sometimes fully formed vesicles or pustules develop. The lesions can be subcutaneous mimicking erythema nodosum which can’t be differentiated unless a biopsy is taken. Because the diagnosis of Sweet syndrome can be challenging, particularly when associated with other connective tissue disorders such as SLE, a set of diagnostic criteria were proposed initially by Su and Liu and then revised by Von den Driesch. The diagnosis is based upon the presence of two major and two of the four minor criteria. Concurrent Sweet syndrome and SLE are exceedingly rare. Twelve patients with both Sweet syndrome and systemic lupus erythematosus (SLE) have been previously reported. We report a case of sweet syndrome associated with SLE diagnosed in our hospital. In our patient, diagnostic criteria are satisfied for Sweet syndrome as well as for SLE (ACR criteria-patient had polyarthralgia, anemia, thrombocytopenia, ANA and Ds DNA positive. Four out of 11 are fulfilled for SLE). Patient responded to corticosteroids.
机译:甜综合征是由Robert Douglas Sweet在1964年首次描述的一种急性发热性中性粒细胞性皮肤病。甜综合征表现为三种临床情况:经典(或特发性),恶性肿瘤相关性和药物诱发的。它与造血系统恶性肿瘤和骨髓增生异常有关。一位28岁的已婚妇女向我们提出了自2个月以来发烧和全身肿胀的主要抱怨。在演示中,她有Pallor;静脉嗡嗡声。多发性,软弱,红斑性皮下肿胀,两前臂的硬度一致。肿胀处的皮肤可捏;浅表皮肤正常。甜综合症偶尔会引起强烈的全身反应,涉及肺,肝和肌肉骨骼系统。甜综合征中的皮肤病变通常始于红斑丘疹,斑块和结节。病变可表现为假囊泡或假脓疱外观,有时会形成完全形成的囊泡或脓疱。病变可能是皮下模仿结节性红斑,除非进行活检,否则无法区分。因为Sweet综合征的诊断可能具有挑战性,特别是当与其他结缔组织疾病(例如SLE)相关时,Su和Liu最初提出了一套诊断标准,然后由Von den Driesch进行了修订。该诊断基于两个主要标准和四个次要标准中的两个。并发的甜综合征和SLE极为罕见。先前已有十二例同时患有Sweet综合征和系统性红斑狼疮(SLE)的患者的报道。我们报告一例在我们医院诊断出的与SLE相关的甜味综合征。在我们的患者中,Sweet综合征和SLE的诊断标准均得到满足(ACR标准-患者患有多关节痛,贫血,血小板减少症,ANA和Ds DNA阳性。SLE满足11个中的4个)。病人对皮质类固醇激素有反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号